GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Inventory-to-Revenue

Longevity Biomedical (Longevity Biomedical) Inventory-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Longevity Biomedical's Average Total Inventories for the quarter that ended in . 20 was $0.00 Mil. Longevity Biomedical's Revenue for the six months ended in . 20 was $0.00 Mil.

Longevity Biomedical's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Longevity Biomedical Inventory-to-Revenue Historical Data

The historical data trend for Longevity Biomedical's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Inventory-to-Revenue Chart

Longevity Biomedical Annual Data
Trend
Inventory-to-Revenue

Longevity Biomedical Semi-Annual Data
Inventory-to-Revenue

Competitive Comparison of Longevity Biomedical's Inventory-to-Revenue

For the Biotechnology subindustry, Longevity Biomedical's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Inventory-to-Revenue falls into.



Longevity Biomedical Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Longevity Biomedical's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

Inventory-to-Revenue (A: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Revenue (A: . 20 )
=( ( + ) / 1 ) /
=0 /
=N/A

Longevity Biomedical's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue (Q: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Revenue (Q: . 20 )
=( ( + ) / 1 ) /
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical  (NAS:LBIO) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Longevity Biomedical's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Longevity Biomedical's Inventory Turnover for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines